Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma
Open Access
Abstract
BACKGROUND: Children with diffuse brainstem glioma (BSG) commonly undergo novel therapies because their outcome is poor with radiation therapy (RT). Although recent clinical trials using new biologic agents documented intratumoral hemorrhage (IH) among several children with BSG, to the authors' knowledge little is known regarding this phenomenon. In the current study, the authors assessed the characteristics and estimated the cumulative incidence of IH among children with BSG.METHODS: All available brain imaging studies and medical records of 48 consecutive patients with newly diagnosed BSG treated at the study institution over a 10‐year interval (1992–2002) were reviewed. Treatment was comprised of RT and various regimens of conventional chemotherapy; none of these patients received biologic agents. At the time of last follow‐up, all patients had died of tumor progression.RESULTS: The authors reviewed 319 imaging studies (251 magnetic resonance imaging scans and 68 computed tomography scans). IH was present in 6.25% of patients at the time of diagnosis. The 6‐month and 12‐month cumulative incidence estimates of IH regardless of the associated symptoms were 15.5% ± 5.5% and 24.4% ± 6.5%, respectively. The same estimates for symptomatic cases were 8.9% ± 4% and 17.8% ± 6%, respectively. All cases of IH at the time of diagnosis and 78% of symptomatic cases that developed after diagnosis were located in necrotic areas.CONCLUSIONS: Although IH is uncommon at the time of diagnosis, symptomatic IH may occur among nearly 20% of children after the diagnosis of BSG. The uniform occurrence of IH among patients treated with various chemotherapeutic regimens and its association with necrotic areas suggests that tumor biology plays a significant role in this event. Cancer 2006. © 2006 American Cancer Society.Keywords
Funding Information
- Cancer Center Support (CORE) Grant from the National Institutes of Health (P30 CA21765)
- American Lebanese Syrian Associated Charities (ALSAC)
This publication has 17 references indexed in Scilit:
- Chemotherapy and novel therapeutic approaches in malignant gliomasFrontiers in Bioscience-Landmark, 2005
- Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in childrenCancer, 2004
- Phase I trial of ZD1839 (Iressa™) and radiation in pediatric patients newly diagnosed with brain stem tumors or incompletely resected supratentorial malignant gliomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Supratentorial High-Grade Astrocytoma and Diffuse Brainstem Glioma: Two Challenges for the Pediatric OncologistThe Oncologist, 2004
- Diffuse brain stem gliomaChild's Nervous System, 1999
- Brain Stem Involvement in Children with Neurofibromatosis Type 1: Role of Magnetic Resonance Imaging and Spectroscopy in the Distinction from Diffuse Pontine GliomaNeurosurgery, 1997
- Brainstem Gliomas in ChildrenPediatric Neurosurgery, 1996
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- Supratentorial malignant gliomas in childhood: A review of fifty casesAnnals of Neurology, 1987
- Spontaneous Intracranial Hemorrhage Caused by Brain TumorNeurosurgery, 1982